University of Hertfordshire

Activation of P2X-like receptors in rat isolated 2nd order mesenteric arteries induces vasodilation: role of EDHF.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Documents

  • Louise Harrington
  • Jane A. Mitchell
View graph of relations
Original languageEnglish
Title of host publicationpA2online
Volume1 issue 2 abst 008P
Publication statusPublished - 2003

Abstract

ATP is released by a range of vascular cells under inflammatory conditions. ATP induces vasodilation in some vascular beds via the release of nitric oxide (NO) and prostacyclin (PGI2) from the endothelium, by way of P2Y receptor activation. Recently, we have shown, using rat perfused mesenteric preparations, that high doses of ATP also induce a profound vasodilator response which we characterised as EDHF-like in nature (Stanford and Mitchell, 1998; Stanford et al., 2001). Furthermore, and by contrast to the initial transient NO-mediated vasodilatation induced by ATP, the ‘EDHF’ component does not appear to be mediated by traditional vasodilator P2Y receptors (Gitlin et al., 2001a), but may be mediated by either a P2X receptor (Gitlin et al., 2002; Ralevic, 2002) or an unidentified purinergic receptor. In order to further understand this phenomenon we have investigated the effects of ATP and the P2X selective ligand α,β methylene ATP on vasomotor tone of isolated 2nd order rat mesenteric arteries.
Male Wistar rats (200 ± 15.4g) were killed by lethal exposure to CO2 followed by cervical dislocation. The mesenteric bed was removed and 2nd order arteries (240-250μm) isolated and mounted in wire myographs using a dissecting microscope. Tissues were immersed in physiological salt solution (PSS), equilibrated (30 min) and tensions normalised as described previously (Mulvany and Halpern, 1977). Vessels were then contracted with approximately EC80 concentration of methoxamine (10-5M). Single concentrations of either ATP, α,β methylene ATP (10-4M each), acetylcholine or sodium nitropruside (10-5M each) were then added to tissues. Dilator responses were calculated as a percentage of tone induced by methoxamine. In some experiments the nitric oxide synthase inhibitor, L-NG nitro-L-arginine (L-NAME; 10-3M), the cyclo- oxygenase inhibitor indomethacin (10-5M), or apamin (5x10-7M)
plus charybdotoxin (10-7M), which together inhibit EDHF responseswere added.
Figure 1: (A) ATP, α,β methylene ATP, acetylcholine (ACh) or sodium nitroprusside (SNP) induced dilation; time control (T.Con.).(B) Effect of L-NAME plus indomethacin (L+I), apamin plus charybdotoxin (A+C),L+I plusA+C (L/I/A/C) or KCl on the vasodilator actions of ATP. Data is shown asthe mean ± s.e.m. for n=3-8 experiments. Significance (one-way ANOVA; p<0.05) between ATP-induced response with or without drugs is denoted by*
Both ATP and α,β methylene ATP induced vasodilation of pre-constricted mesenteric vessels. In both cases vasodilation wasinsensitive to the combination of L-NAME and indomethacin, but reduced by the combination of apamin plus charybdotoxin or highKCl (124x10-3M).
Here we have reproduced a phenomenon previously only noted inintact perfused mesenteric beds where either ATP or a selective P2Xligand induces vasodilation, and is possibly mediated by EDHF.Since P2X receptors have previously been linked to vasoconstrictorresponses, these findings prompt us to re-examine the role of P2Xreceptors in the regulation of vasomotor tone.
Acknowledgements: This work was funded by the British Heart Foundation
Gitlin, JM, Stanford, SJ, Evans TW et al (2001a) Br J Pharmacol, 134; 22
Gitlin, JM,Stanford, SJ, Evans TW et al (2001b) Br J Pharmacol, 134; 23P
Gitlin JM, Zanesco A, Stanford SJ et al. (2002) Br. J Pharmacol, 135: 210P
Mulvany MJ and Halpern W (1977) Circ Res 41:19-26
Ralevic, V (2002) Br J Pharmocol, 135(8):1988-94
Stanford, S, Mitchell JA, Br J Pharmacol. 125, (1998), P94
Stanford, SJ, Gitlin, JM. Mitchell, JA (2001) Br J Pharmacol 133,825-32

ID: 2042651